However, traditional fed-batch manufacturing systems struggle to keep pace with increasing production demands. In addition, dynamic conditions within the bioreactor can lead to an imbalance of ...
The versatility of biological products to treat disease never before considered has led numerous biopharmaceutical companies recently to announce expansions of production bioreactor capacity in the ...
From cultivated meat to plant-based proteins, engineering innovation is transforming how we produce and consume protein in a ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that secures its leadership position in the global stem cell ...
Enduro Genetics, a Denmark-based start-up, aims to increase efficiency in biomanufacturing. By getting producing cells ...
Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...
A multidisciplinary team of scientists from Tomsk Polytechnic University supported by the Priority 2030 federal program of ...
Rebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking “exozymes” as a ...
By leveraging CytoImmune's Bioreactor technologies, Hemostemix secures an allogenic supply of stem cells that strategically complements its autologous offering. This creates a "stem cell fence" -a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback